1. The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
    Lin Li et al, 2023, Drug Design, Development and Therapy CrossRef
  2. Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating MIR-21/PTEN/PI3K/AKT Signaling
    Xuxi Guo et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
  3. Clinical Features and Rules of Chinese Herbal Medicine in Diabetic Peripheral Neuropathy Patients
    Jindong Zhao et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  4. Research Progress on the Regulatory Mechanisms and Carriers of Astragaloside on Wound Healing Cascade Related Factors
    善钊 刘, 2024, Traditional Chinese Medicine CrossRef
  5. Yiqi Huoxue Recipe Improves Liver Regeneration in Rats after Partial Hepatectomy via JNK Pathway
    Wen-cong Li et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  6. Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro
    Xiao Shao et al, 2021, Molecular and Cellular Biochemistry CrossRef
  7. Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress
    Peipei Meng et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  8. Astragaloside IV (ASIV) Mediates Endothelial Progenitor Cell (EPC) Exosomal LINC01963 to Inhibit Pyroptosis and Oxidative Stress in High Glucose-impaired Endothelial Cells
    Wu Xiong et al, 2024, Current Molecular Medicine CrossRef
  9. Protective effect of astragalus membranaceus and its bioactive compounds against the intestinal inflammation in Drosophila
    Jianzheng He et al, 2022, Frontiers in Pharmacology CrossRef
  10. Review on the protective mechanism of astragaloside IV against cardiovascular diseases
    Chunkun Yang et al, 2023, Frontiers in Pharmacology CrossRef
  11. Research Progress of Astragalus and Its Active Ingredients in the Treatment of Ne-phrotic Syndrome
    琳 杜, 2024, Advances in Clinical Medicine CrossRef
  12. The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy
    Ziyu Li et al, 2022, Drug Design, Development and Therapy CrossRef